1. Introduction {#sec1}
===============

The incidence of obesity is rising rapidly across developed countries, with current prevalence in the United States (35.7%) and United Kingdom (26.1%) expected to double by 2050 \[[@B1], [@B2]\]. Estimates predict that up to 66% of patients undergoing surgery in the UK were overweight. Current evidence conflicts regarding the impact of obesity on postoperative complications following major surgery. Multicentre studies in specific patient groups from Japan, Denmark, Switzerland, and the USA have associated obesity with worse or neutral short term postoperative outcomes \[[@B3]--[@B7]\].

Despite this, limited evidence exists surrounding the benefit of preoperative management of obese patients in dedicated high risk preassessment clinics and its implications on postoperative outcomes such as complications and length of hospital stay. The recently published guidelines by the Association of Anaesthetists of Great Britain & Ireland (AAGBI) recommended that all obese patients receive preoperative assessment by an anaesthetist in high risk clinics \[[@B8]\]. However, clinical evidence behind this recommendation is lacking and instead this is largely based on expert opinion. Since the variable of interest was body mass index (BMI), randomised trials assigning patients to preassessment clinics are not possible.

To build on the limited literature and offer further clarification on the need for preassessment stratification by BMI, this prospective study sought to evaluate the impact of BMI on postoperative outcomes in patients undergoing preoperative assessment for gastrointestinal surgery.

2. Methods {#sec2}
==========

2.1. Inclusion and Exclusion Criteria {#sec2.1}
-------------------------------------

This prospective study identified patients attending preassessment screening clinic (PAS) for minor to major gastrointestinal surgery attending from August 2016 to September 2016 at the Queen Elizabeth Hospital Birmingham (QEHB). Consecutive, adult patients (≥18 years) with a BMI \> 30 kg/m^2^ undergoing gastrointestinal or hepatobiliary surgery were included in the study. Eligible procedures were those involving surgery on any part of the gastrointestinal tract or biliary tree, involving a hospital admission with an overnight stay. Patients undergoing day-case urological, gynaecological, vascular, or transplant procedures were excluded. This study was registered and approved by the local audit department. Patients\' medical records were reviewed and the data were extracted on to a uniform database (Microsoft® Excel 2010) that was designed to include all relevant details pertinent to this study.

2.2. Preassessment Clinics {#sec2.2}
--------------------------

At QEHB, all patients undergoing surgical procedures were referred by the surgeon to dedicated preassessment clinics according to surgery grade and comorbidities. Clinics were divided into low risk and high risk; numerically these corresponded to levels 1 and 2A and 2B and 3, respectively. Low risk clinics were led and delivered by trained preassessment nurses whereas high risk clinics were led and delivered by more experienced nursing staff and consultant anaesthetists. As no systematic method for stratifying risk was in place, each patient was assigned a PAS clinic based on a preliminary individual risk assessment by the referring surgeon.

2.3. Main Explanatory Variable {#sec2.3}
------------------------------

The main explanatory variable was preoperative BMI, assessed during attendance at PAS clinic. BMI was calculated as weight (in kilograms) divided by height (in metres) squared. Given the primary aim of this study which was to assess the impact of being overweight or obese, patients were stratified by BMI into groups defined by the World Health Organization (WHO): normal weight (BMI 18.5--24.9 kg/m^2^), overweight (BMI 25.0--29.9 kg/m^2^), and obese (BMI ≥ 30.0 kg/m^2^).

2.4. Explanatory Variables {#sec2.4}
--------------------------

Explanatory variables were collected to provide a risk‐adjusted estimates. Variables were predefined and selected based on clinical plausibility. Comorbidities were measured using the American Society of Anesthesiologists (ASA) fitness grade, a standardised metric for disease severity and a reliable method for the measurement of postoperative mortality and complications \[[@B9]\]. Grade of surgery is a category that indicates a combination of complexity and amount of tissue injury in the surgical procedure. Exact definitions used were similar to those in a recent publication from the European Surgical Outcomes Study \[[@B10]\]. Surgical approach was defined as open, laparoscopic, or endoscopic/ultrasound (for minor surgical grade only).

2.5. Outcome Measures {#sec2.5}
---------------------

The primary outcome measure was 30-day complications as defined by the Clavien-Dindo classification system \[[@B11]\]. Secondary outcome measures were major complications, 30-day readmission rates, and postoperative care setting.

2.6. Statistical Analysis {#sec2.6}
-------------------------

This study was powered to detect a minimum significant difference between normal weight, overweight, and obese patients. A minimum of 356 patients were needed to provide 80% power (*α* = 0.05). Baseline characteristics were compared between groups using Pearson chi-square (*χ*^2^) test for categorical variables and Mann--Whitney *U* test for continuous variables. Multivariate logistic regression was used to determine the strength association between risk factors for postoperative complications. Models built included age, sex, ethnicity, grade of surgery, presence of specific comorbid diseases, surgical specialty, and surgical approach. Results are presented as hazard ratios (HRs) with 95 per cent confidence interval (CI~95%~). In all analyses, a *p* value of \< 0.05 was maintained as statistically significant. All data analyses were performed using IBM SPSS Statistics Version 22.0.

3. Results {#sec3}
==========

3.1. Baseline Demographics {#sec3.1}
--------------------------

During this study period, 376 patients were identified through PAS and only 2% (8/376) had cancellations for their procedure and hence were not included in further analysis. Baseline demographics of patients who had preassessment and then went on to have surgery are presented in [Table 1](#tab1){ref-type="table"}. Of these 368 patients, 33% (122/368) were of normal weight, 31% (116/368) were overweight, and 35% (130/368) were obese. Median age is 57 (range: 17--93) and 55% (204/368) were male.

There was no significant difference in surgery grade between the BMI groups (*p* = 0.185). However, 48% of obese patients had \>2 comorbidities as compared to 30% and 40% in overweight and normal BMI patients (*p* = 0.034), respectively. Furthermore 26% of obese patients had ASA grades 3 or 4 as compared to 16% and 13% in the overweight and normal BMI groups (*p* \< 0.001), respectively.

3.2. Surgery Types {#sec3.2}
------------------

The most common indications for surgery were malignancy accounting for 25% of cases followed by hernia (23%) and cholecystitis (18%). In normal and overweight patients, malignancy was the most common indication for surgery followed by hernia repair and cholecystitis. In obese patients, both malignancy (22%) and cholecystitis (22%) were the most common indications followed by hernia repair. However, appendicitis was the least most common indication for surgery in this cohort and across different BMI groups. The indications for surgery in this cohort are presented in [Table 2](#tab2){ref-type="table"}.

3.3. Postoperative Outcomes {#sec3.3}
---------------------------

Overall complication rates were 14% (52/368), with 3% (10/368) having major complications (Grades III-IV). Postoperative outcomes are presented in [Table 3](#tab3){ref-type="table"}. Rates of overall postoperative complications and major complications were similar across the BMI categories (*p* = 0.854, *p* = 0.950, respectively). There was no significant difference in 30-day readmission rates (*p* = 0.827).

Multivariate logistic regression was produced to identify the impact of BMI on postoperative outcomes. In adjusted models accounting for covariates presented in [Table 4](#tab4){ref-type="table"}, there was no impact of BMI on overall complications (overweight, HR: 1.34 (CI~95%~: 0.55--3.27), *p* = 0.52; obese, HR: 1.32 (CI~95%~: 0.54--3.24), *p* = 0.55). When stratified by surgical grade, there was no significant impact of BMI on postoperative complications.

3.4. Characteristic by Preassessment Clinic {#sec3.4}
-------------------------------------------

In this cohort, 28% of patients were seen in the high risk clinic (levels 2B and 3). There were significantly more patients in the high risk clinic with \>2 comorbidities than the low risk clinic (54% versus 34%, *p* \< 0.001). Sixty-six percent (66%) of patients seen in the high risk clinic underwent a major surgical procedure (*p* \< 0.001) as compared to only 8% in the low risk clinic. There was a significantly higher rate of open procedures (57% versus 29%, *p* \< 0.001) and surgeries for malignant indication (51% versus 13%, *p* \< 0.001) in the high risk clinic as compared to the low risk clinic. No significant differences in ASA grade or BMI were observed between the groups.

3.5. Postoperative Outcomes by Preassessment Clinic {#sec3.5}
---------------------------------------------------

Following surgery, 88% of patients from the high risk clinic were sent to either ward or enhanced care for recovery. This contrasts with only 20% from the low risk clinic. There were significantly higher rates of overall complications (31% versus 8%, *p* \< 0.001) and major complications (7% versus 1%, *p* = 0.003) in the high risk clinic as compared to the low risk clinic. There were also higher 30-day readmission rates in patients seen in high risk clinics as compared to those seen in low risk clinics (14% versus 4%, *p* = 0.001).

3.6. Cancellation Rates {#sec3.6}
-----------------------

Eight patients had cancelled surgery, of which 6 were from the nurse-led low risk clinic. Of these 6 patients, 2 patients had their surgery deferred due to poor diabetic control, 1 refused surgery on the day of procedure, and 1 was admitted for abdominal pain before surgery. One patient scheduled for a Nissen fundoplication felt unsuitable to proceed for surgery by the surgeon on the day of procedure due to high BMI (38.2 kg/m^2^).

4. Discussion {#sec4}
=============

This study aimed at assessing the need for BMI as a factor for stratifying patients into PAS clinics. Results of this study demonstrate that surgical grade rather than BMI is an independent risk factor for overall complications. When the cohort was stratified by surgical grade, BMI remains a nonsignificant factor in overall complications.

Currently, there is conflicting evidence as to the importance of BMI as a risk factor for postoperative complications. Evidence suggests that obese patients undergoing surgery for a malignant indication are at an increased risk of complications \[[@B12], [@B13]\]. However, this increased risk is not observed in patients undergoing surgery for a benign indication. Such findings demonstrate that obese patients undergoing surgery for a malignant indication may need to be seen in high risk clinics. A systematic review of patients undergoing laparoscopic colorectal surgery concluded that BMI was not a predictor of increased postoperative complication rates or length of hospital stay \[[@B14]\].

Despite these papers demonstrating varying evidences for the impact of BMI, preassessment services do not consider BMI as a risk factor during triage. Current literature on the approach to preassessment in the context of BMI and obesity is limited, and although advocating that a nurse-led and consultant/specialist-led PAS clinic is feasible, this service remains largely undefined considering the range of surgical specialties \[[@B15]--[@B17]\]. At QEHB, this two-tiered screening clinic was recently introduced to allow assessment of patients by risk groups based on their comorbidities and ASA grade. This service allows risk assessment of patients for their comorbidities such as diabetes and cardiovascular disease prior to surgery. This was achieved by means of referral to the medical specialty of concern for review and advice prior to surgery. This aimed at reducing cancellations on the day of surgery and postoperative complications.

One of the limitations to this study is that data was derived from a single centre. Our results require validation from multiple centres using a similar approach to preassessment of obese patients. Nonetheless, this study remains the first in the literature reporting outcomes in preassessment services for patients undergoing gastrointestinal surgery. Furthermore, this study accounts for varying grade of surgical procedure making it difficult to assess need for BMI for triaging. Subgroup analysis demonstrated that BMI did not impact outcomes when stratified by surgical grade. This study only included patients undergoing elective procedures and hence results may not be comparable to previous studies including both elective and emergency procedures.

5. Conclusion {#sec5}
=============

In summary, specific triaging for BMI may not be required for preassessment clinics in patients undergoing gastrointestinal surgeries. However, future prospective studies should aim to confirm these findings and help establish the need for consideration of BMI in planning patient triage and perioperative management.
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###### 

Baseline characteristics of patients by body mass index (BMI).

  ----------------------------------------------------------------------------------
  Variable                 Normal,\      Overweight,\   Obese,\       *p* value
                           *n* (%)       *n* (%)        *n* (%)       
  ------------------------ ------------- -------------- ------------- --------------
  Age (range)              60 (17--92)   52 (19--83)    58 (21--87)    

  Sex                                                                  

   Male                    74 (61)       74 (64)        56 (43)       0.002^*∗*^

   Female                  48 (39)       42 (36)        74 (57)       

  Comorbidity                                                          

   0                       20 (16)       25 (22)        14 (11)       0.034^*∗*^

   0-1                     53 (43)       56 (48)        53 (41)       

   \>2                     49 (40)       35 (30)        63 (48)       

  ASA grade                                                            

   1                       19 (16)       26 (22)        0 (0)         \<0.001^*∗*^

   2                       87 (71)       72 (62)        95 (74)       

   3                       15 (12)       17 (15)        32 (25)       

   4                       1 (1)         1 (1)          1 (1)         

  Surgical grade                                                       

   Minor                   40 (33)       44 (38)        39 (30)       0.185

   Intermediate            50 (41)       40 (35)        65 (50)       

   Major                   32 (26)       31 (27)        26 (20)       

  Surgical type                                                        

   Upper GI                37 (30)       22 (19)        25 (19)       0.042^*∗*^

   Lower GI                35 (29)       51 (44)        45 (35)       

   HPB                     50 (41)       42 (37)        60 (46)       

  Indication                                                           

   Benign                  92 (75)       86 (74)        102 (78)      0.713

   Malignant               30 (25)       30 (26)        28 (22)       

  Operative approach                                                   

   Endoscopic/ultrasound   37 (30)       43 (37)        42 (32)       0.104

   Laparoscopic            35 (29)       27 (23)        49 (38)       

   Open                    50 (41)       46 (40)        39 (30)       

  Smoking status                                                       

   Current                 60 (49)       66 (57)        68 (53)       0.224

   Ex-smoker               30 (25)       30 (26)        24 (19)       

   Never                   32 (26)       18 (16)        35 (27)       

   Unknown                 0 (0)         2 (2)          2 (2)         
  ----------------------------------------------------------------------------------

Upper Gastrointestinal Surgery (Upper GI), Lower Gastrointestinal Surgery (Lower GI), and hepatobiliary surgery (HPB). *∗* means that these variables are significant when tested using chi-square.

###### 

Surgical indications.

  -----------------------------------------------------------------------
  Indications                         Normal,\   Overweight,\   Obese,\
                                      *n* (%)    *n* (%)        *n* (%)
  ----------------------------------- ---------- -------------- ---------
  Malignant                           32 (26)    30 (26)        29 (22)

  Hernia                              30 (25)    27 (23)        27 (21)

  Cholecystitis                       20 (16)    18 (16)        29 (22)

  All other indications               8 (6)      12 (11)        12 (9)

  Diagnostic chronic liver disease    7 (6)      5 (4)          8 (6)

  Anal fistula                        6 (5)      11 (9)         6 (5)

  Haemorrhoids                        5 (4)      5 (4)          7 (5)

  Inflammatory bowel disease          5 (4)      2 (2)          0 (0)

  Other liver or pancreatic disease   4 (3)      1 (1)          6 (5)

  Gastrooesophageal reflux            3 (2)      2 (2)          2 (2)

  Pancreatitis                        1 (1)      1 (1)          0 (0)

  Faecal incontinence                 1 (1)      1 (1)          3 (2)

  Appendicitis                        0 (0)      0 (0)          1 (1)

  Diverticular disease                0 (0)      1 (1)          0 (0)
  -----------------------------------------------------------------------

###### 

Postoperative outcomes by BMI.

  ------------------------------------------------------------------------------
  Variable                      Normal,\   Overweight,\   Obese,\    *p* value
                                *n* (%)    *n* (%)        *n* (%)    
  ----------------------------- ---------- -------------- ---------- -----------
  Postoperative complications                                         

   No                           106 (87)   98 (84)        112 (86)   0.854

   Yes                          16 (13)    18 (16)        18 (15)    

  Major Complications                                                 

   No                           119 (98)   113 (97)       126 (97)   0.950

   Yes                          3 (2)      3 (3)          4 (3)      

  30-day readmission rate                                             

   No                           113 (94)   108 (93)       118 (92)   0.827

   Yes                          7 (6)      8 (7)          10 (8)     

  Unplanned CCA                                                       

   No                           118 (97)   112 (97)       125 (97)   0.716

   Yes                          4 (3)      3 (3)          4 (3)      
  ------------------------------------------------------------------------------

Critical care admission (CCA).

###### 

Multivariate model.

  Variables                HR (CI~95%~)           *p* value
  ------------------------ ---------------------- -----------
  Age                      1.02 (1.00--1.04)      0.123
  Sex                                              
   Male                    REF                    ---
   Female                  2.12 (1.01--4.44)      0.047
  Comorbidity                                      
   0                       REF                    ---
   0-1                     1.82 (0.43--7.74)      0.419
   \>2                     1.57 (0.33--7.46)      0.571
  ASA grade                                        
   1                       REF                    ---
   2                       0.58 (0.14--2.43)      0.456
   3                       1.15 (0.23--5.65)      0.865
   4                       ---                    0.999
  Surgical grade                                   
   Minor                   REF                    ---
   Intermediate            1.93 (0.25--14.89)     0.529
   Major                   21.64 (2.24--209.49)   0.008
  Surgical type                                    
   Upper GI                REF                    ---
   Lower GI                0.71 (0.26--1.93)      0.504
   HPB                     0.54 (0.21--1.40)      0.206
  Indication                                       
   Benign                  REF                    ---
   Malignant               0.88 (0.36--2.16)      0.782
  Operative approach                               
   Endoscopic/ultrasound   REF                    ---
   Laparoscopic            0.95 (0.12--7.66)      0.957
   Open                    1.30 (0.16--10.64)     0.807
  PAS clinic                                       
   Low risk                REF                    ---
   High risk               0.98 (0.38--2.56)      0.971
  BMI                                              
   Normal                  REF                    ---
   Overweight              1.34 (0.55--3.27)      0.519
   Obese                   1.32 (0.54--3.23)      0.547

Upper Gastrointestinal Surgery (Upper GI), Lower Gastrointestinal Surgery (Lower GI), hepatobiliary surgery (HPB), preassessment service (PAS), and body mass index (BMI).
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